Multifocal Tender Lymphadenopathy with Eosinophilia and Neutropenia During Linezolid Therapy in a Child: A Probable Adverse Drug Reaction
Year: 2026
Type: preprint
Study design: Case Report
Abstract: Background: Linezolid is an important treatment option for resistant gram-positive infections when conventional agents cannot be used. Reversible myelosuppression is well recognized, whereas hypersensitivity is rare and predominantly cutaneous, renal or systemic. Case: A 9-year-old boy with a right below-knee amputation was treated for stump cellulitis with possible early osteomyelitis. Because a previous stump isolate was methicillin-resistant Staphylococcus aureus, vancomycin had caused a diffuse rash and clindamycin was temporarily unavailable, intravenous linezolid 10 mg/kg every 8 hours was started. Approximately 5 days later, he developed tender right inguinal and submental lymphadenopathy and malaise near the end of each linezolid infusion. He remained afebrile and had no rash, facial edema, mucosal disease or renal, hepatic or pulmonary injury. The absolute eosinophil count increased from 480 to 702 cells/µL, the absolute neutrophil count decreased from 3,800 to 800 cells/µL, and the platelet count reached 139 × 10³/µL. Linezolid was withdrawn after approximately 9 days; lymph node tenderness improved within 24 hours and laboratory abnormalities improved within 3 days without corticosteroids. Clindamycin was reintroduced without recurrence. Conclusions: The Naranjo score was 5, indicating a probable adverse drug reaction, while RegiSCAR excluded DRESS. No previous report identified by a focused literature review described lymphadenopathy as the predominant manifestation of a linezolid-associated reaction. New multifocal lymphadenopathy arising during linezolid therapy should raise suspicion of a drug-related reaction even without rash or systemic organ involvement.
Source: Preprints.org
Language: English
Subfield: Toxicology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7235389073
